GlassScriptPhysician profile
Brianna D Niehoff
NPI 1154981850
$650.89
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.71 · 2021: $151 · 2022: $214 · 2023: $117 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $99.68 | 2020-2022 | |
| Alcon Vision LLC | $91.65 | 2022-2023 | Total30 |
| Aerie Pharmaceuticals, INC. | $73.29 | 2021 | |
| Coherus Oncology, INC. | $64.06 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.92 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $39.24 | 2022 | |
| Apellis Pharmaceuticals, INC. | $33.12 | 2023-2024 | Syfovre |
| Johnson & Johnson Vision Care, INC. | $26.84 | 2020-2022 | |
| Lkc Technologies, INC. | $26.26 | 2024 | |
| Harrow Eye, LLC | $24.49 | 2024 | Triesence, Iheezo |
| Genentech USA, INC. | $23.92 | 2024 | Vabysmo |
| Abbvie INC. | $23.01 | 2022 | |
| Rayner Intraocular Lenses Limited | $18.66 | 2024 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Coopervision INC. | $18.18 | 2021 | |
| Bausch & Lomb Americas INC. | $17.38 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $15.86 | 2021 | |
| Oyster Point Pharma, INC. | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianna Niehoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.